BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 26585799)

  • 1. The endocannabinoid system in guarding against fear, anxiety and stress.
    Lutz B; Marsicano G; Maldonado R; Hillard CJ
    Nat Rev Neurosci; 2015 Dec; 16(12):705-18. PubMed ID: 26585799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating endocannabinoid signaling in the regulation of anxiety and depression.
    Yin AQ; Wang F; Zhang X
    Acta Pharmacol Sin; 2019 Mar; 40(3):336-341. PubMed ID: 30002489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental regulation of fear learning and anxiety behavior by endocannabinoids.
    Lee TT; Hill MN; Lee FS
    Genes Brain Behav; 2016 Jan; 15(1):108-24. PubMed ID: 26419643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.
    Vimalanathan A; Gidyk DC; Diwan M; Gouveia FV; Lipsman N; Giacobbe P; Nobrega JN; Hamani C
    Neuropharmacology; 2020 Apr; 166():107965. PubMed ID: 31962287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocannabinoid system in modulating fear, anxiety, and stress
.
    Maldonado R; Cabañero D; Martín-García E
    Dialogues Clin Neurosci; 2020 Sep; 22(3):229-239. PubMed ID: 33162766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic stress induces anxiety via an amygdalar intracellular cascade that impairs endocannabinoid signaling.
    Qin Z; Zhou X; Pandey NR; Vecchiarelli HA; Stewart CA; Zhang X; Lagace DC; Brunel JM; Béïque JC; Stewart AF; Hill MN; Chen HH
    Neuron; 2015 Mar; 85(6):1319-31. PubMed ID: 25754825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels.
    Jenniches I; Ternes S; Albayram O; Otte DM; Bach K; Bindila L; Michel K; Lutz B; Bilkei-Gorzo A; Zimmer A
    Biol Psychiatry; 2016 May; 79(10):858-868. PubMed ID: 25981172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders.
    Gorzalka BB; Hill MN; Hillard CJ
    Neurosci Biobehav Rev; 2008 Aug; 32(6):1152-60. PubMed ID: 18433869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
    Lisboa SF; Gomes FV; Silva AL; Uliana DL; Camargo LH; Guimarães FS; Cunha FQ; Joca SR; Resstel LB
    Int J Neuropsychopharmacol; 2015 Jan; 18(8):. PubMed ID: 25618404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2.
    Lisboa SF; Niraula A; Resstel LB; Guimaraes FS; Godbout JP; Sheridan JF
    Neuropsychopharmacology; 2018 Aug; 43(9):1924-1933. PubMed ID: 29786066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-endocannabinoid uncoupling mediates fear suppression deficits after early - Life stress.
    Atsak P; Morena M; Schoenmaker C; Tabak E; Oomen CA; Jamil S; Hill MN; Roozendaal B
    Psychoneuroendocrinology; 2018 May; 91():41-49. PubMed ID: 29524763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoids and stress.
    Riebe CJ; Wotjak CT
    Stress; 2011 Jul; 14(4):384-97. PubMed ID: 21663537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal populations mediating the effects of endocannabinoids on stress and emotionality.
    Häring M; Guggenhuber S; Lutz B
    Neuroscience; 2012 Mar; 204():145-58. PubMed ID: 22233782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease.
    Wyrofsky R; McGonigle P; Van Bockstaele EJ
    Expert Opin Drug Discov; 2015 Jan; 10(1):17-36. PubMed ID: 25488672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxious moments for the protein tyrosine phosphatase PTP1B.
    Krishnan N; Tonks NK
    Trends Neurosci; 2015 Aug; 38(8):462-5. PubMed ID: 26166619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the serotonin system by endocannabinoid signaling.
    Haj-Dahmane S; Shen RY
    Neuropharmacology; 2011 Sep; 61(3):414-20. PubMed ID: 21354188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of the Endocannabinoid System in the Central Nervous System.
    Hu SS; Mackie K
    Handb Exp Pharmacol; 2015; 231():59-93. PubMed ID: 26408158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoids: stress, anxiety, and fear.
    Taber KH; Hurley RA
    J Neuropsychiatry Clin Neurosci; 2009; 21(2):iv, 109-13. PubMed ID: 19622681
    [No Abstract]   [Full Text] [Related]  

  • 19. Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation.
    Bluett RJ; Gamble-George JC; Hermanson DJ; Hartley ND; Marnett LJ; Patel S
    Transl Psychiatry; 2014 Jul; 4(7):e408. PubMed ID: 25004388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in hippocampal response to endocannabinoids after exposure to severe stress.
    Zer-Aviv TM; Akirav I
    Hippocampus; 2016 Jul; 26(7):947-57. PubMed ID: 26928784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.